| Up
2004P-0360:
ANDA Suitability for Ferrlecit Injection 5 ml/62.5 mg of elemental iron
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 08/09/2004
|
| 08/10/2004
|
| Private Industry
|
| AAC Consulting Group
|
|
|
|
|
|
|
| pdf, Attachment A, Attachment B
|
|
|
|
|
| Signature:
|
| Anthony C. Celeste
|
|
|
|
|
| ACK1
|
| 08/10/2004
|
| 08/10/2004
|
| Federal Government
|
| HFA-305 to AAC Consulting Group
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
|
|
|
| C1
|
| 08/18/2004
|
| 08/18/2004
|
| Drug Industry
|
| Watson Pharma, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Charles J. Raubicheck
|
|
|
|
|
| PAV1
|
| 03/17/2006
|
| 03/17/2006
|
| Federal Government
|
| HFD-600 to AAC Consulting Group
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Gary J. Buehler
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated
April 26, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
